Schedule 13D ownership disclosure
PELTHOS THERAPEUTICS INC
Common Stock, par value $0.0001 per share · CUSIP: 171126204
Event date: 2025-11-06
- Filing-level shares
- 5,189,177.1
- Percent of class
- 49.9%
- Ligand Pharmaceuticals IncorporatedReported CIK 0000886163
Shares: 5,189,177.1 · Class: 49.9%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-25-274432
- Form type
- SCHEDULE 13D/A
- Filer
- LIGAND PHARMACEUTICALS INC
- CIK
- CIK 886163
- Filed
- Nov 10, 2025
- Reporting period
- Nov 06, 2025
- Description
- Schedule 13D beneficial ownership